Talymed® advanced sterile wound matrix is composed of shortened fibers of poly-N-acetyl glucosamine (pGlcNac), isolated from microalgae.
• Accelerates wound closure by reepithelialization and increased keratinocyte migration
Talymed® is indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular and other bleeding surface wounds, abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers and dehisced surgical wounds.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Talymed® is packaged in a blister pack and can be stored at room temperature for up to three years.
|Biosynthetic - animal-based|
|Indicated for chronic vascular ulcers||●|
|Indicated for diabetic ulcers||●|
|Indicated for draining wounds|
|Indicated for partial- and full-thickness wounds||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for trauma wounds||●|
|Indicated for venous ulcers||●|
|Variety of sizes|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Open blister pack onto sterile field, position Talymed® onto the wound bed to ensure 100% coverage and affix to skin using adhesive skin closure tape. Talymed® conforms to wound bed. Apply non-adherent primary dressing and secondary dressing based on wound characterization and amount of exudate.
Talymed® advanced wound matrix is composed of shortened fibers of poly-N-acetyl glucosamine (pGlcNAc) isolated from microalgae.
Marine Polymer Technologies, Inc. (MPT) is a medical device company focused on the development and delivery of biomaterials for the medical field. Marine Polymer Technologies, Inc. has introduced advanced products in the areas of wound healing, hemostasis and the control of severe bleeding to support health care providers and their patients.